Neurogenetics delves into how genetic factors impact neurological disorders such as Alzheimer's disease and dementia. In Alzheimer's, mutations in genes like APP, PSEN1, and PSEN2 heighten vulnerability by disrupting amyloid-beta processing and tau protein regulation. Meanwhile, dementia, encompassing various forms of cognitive decline, also shows genetic links, notably with the APOE gene variant ε4 increasing the risk of late-onset Alzheimer's. Studying these genetic nuances is crucial for early detection and personalized treatment approaches. Unraveling these genetic foundations not only deepens our understanding of disease mechanisms but also paves the way for tailored therapies and preventive strategies in the future.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China